Chaim Lebovits
individual
About
Chaim Lebovits is President and Chief Executive Officer of BrainStorm Cell Therapeutics, where he joined in July 2007 and became CEO in September 2015. He has been closely associated with the development and financing of BrainStorm's NurOwn cell-therapy program for ALS and other neurodegenerative diseases. SEC disclosure also says he controls ACC Holdings International and its subsidiary ACC BioTech, and notes prior leadership roles in natural-resource businesses.
Areas of interest
biotechregenerative medicinecell therapyALSneurodegenerative diseaseprecision medicinenatural resources